Otamendi Hospital, Buenos Aires, Argentina.
EuroIntervention. 2013 Dec;9(8):975-8. doi: 10.4244/EIJV9I8A163.
We sought to explore whether global and regional scientific output in cardiovascular medicine is associated with economic variables and follows the same trend as medicine and as science overall.
We registered the number of documents, number of citations, citations per document and the h-index for the first 50 countries according to the h-index (a measure to evaluate both the productivity and impact of the publications) in cardiovascular medicine. Economic variables (gross domestic product [GDP] per capita, % expenditure of the GDP in research and development [R&D] and health) were obtained from the World Bank, the UNESCO, and the World Health Organization. In total, the scientific output in cardiology showed the same position as in medicine and science overall (mean difference vs. medicine -0.9±5.3º, p=0.25 vs. science -0.7±5.3º, p=0.39). We found significant correlations between the h-index and the % GDP expenditure in R&D (r=0.67, p<0.001), and the % GDP expenditure in health (r=0.71, p<0.0001). Overall, there was a 21.4% (interquartile range 3.7; 55.0) increase in the % GDP expenditure in R&D between 1996 and 2007. Emerging economies showed the larger growth in % GDP expenditure in health and R&D.
The global situation of scientific output in cardiovascular medicine is highly polarised and closely related to economic indicators. Emergent economies, with higher rates of GDP growth and increasingly larger expenditures for R&D and healthcare, are expected to show a visible escalation in the scientific global picture in the near future.
我们试图探讨心血管医学的全球和区域科学产出是否与经济变量相关,以及是否与医学和整个科学领域的趋势一致。
我们根据心血管医学领域的 h 指数(一种评估出版物的生产力和影响力的指标),对前 50 个国家的文献数量、引文数量、每篇文献的引文数和 h 指数进行了登记。经济变量(人均国内生产总值 [GDP]、研发 [R&D] 支出占 GDP 的百分比和卫生支出占 GDP 的百分比)来自世界银行、联合国教科文组织和世界卫生组织。总的来说,心脏病学的科学产出与医学和整个科学领域的产出处于相同的地位(与医学相比的平均差异-0.9±5.3°,p=0.25 与科学相比-0.7±5.3°,p=0.39)。我们发现 h 指数与 R&D 支出占 GDP 的百分比(r=0.67,p<0.001)和卫生支出占 GDP 的百分比(r=0.71,p<0.0001)之间存在显著相关性。总的来说,1996 年至 2007 年间,R&D 支出占 GDP 的百分比增长了 21.4%(四分位距 3.7;55.0)。新兴经济体在卫生和研发支出占 GDP 的百分比方面显示出更大的增长。
心血管医学科学产出的全球形势高度两极化,与经济指标密切相关。新兴经济体 GDP 增长率较高,对 R&D 和医疗保健的支出也越来越大,预计在不久的将来,它们在全球科学领域的地位将显著提高。